A cost-effectiveness and safety analysis of dual antiplatelet therapy comparing aspirin–clopidogrel to aspirin–ticagrelor in patients with acute coronary syndrome

A cost-effectiveness and safety analysis of dual antiplatelet therapy comparing aspirin–clopidogrel to aspirin–ticagrelor in patients with acute coronary syndrome

Background: Dual antiplatelet therapy (DAPT) using either an aspirin–clopidogrel (A–C) combination or aspirin–ticagrelor (A–T) combination has become the standard therapy for acute coronary syndrome (ACS). Ticagrelor shows better pharmacokinetic profiles but is more expensive. This study aimed to co...

Full description

Bibliographic Details
Main Authors: Nafrialdi Nafrialdi, Novita M. Handini, Instiaty Instiaty, Ika P. Wijaya
Format: Article
Language:English
Published: Faculty of Medicine Universitas Indonesia 2018-12-01
Series:Medical Journal of Indonesia
Subjects:
acute coronary syndrome
clopidogrel
dual antiplatelet therapy
ticagrelor
Online Access:http://mji.ui.ac.id/journal/index.php/mji/article/view/3024

Similar Items

Similar Items